文献速递角膜与眼表疾病

LVP角膜假体在双侧终末期角膜盲中的解剖与功能结局

LVP keratoprosthesis: anatomical and functional outcomes in bilateral end-stage corneal blindness.
PubMed 文献 · Br J Ophthalmol · 2018-06-11

这项前瞻性病例系列纳入56例(58眼)双侧严重角膜病变且眼表完全干燥的患者,行单侧LVP角膜假体植入。术后1年解剖保留率为90.8%±3.9%,中位最佳矫正视力从光感提升至20/70(p<0.0001),约61.5%的眼维持20/400或更好视力。

要点

  • LVP角膜假体植入术后1年解剖保留率为90.8%±3.9%,2年为80%±5.7%。
  • 术后1年中位BCVA从光感提升至20/70(p<0.0001),61.5%的眼维持20/400或更好。
  • 常见并发症包括假体后膜形成(43%)、青光眼(26%)和玻璃体炎(22%)。

核心结论

  • LVP角膜假体是治疗眼表完全干燥的终末期角膜盲的有效方法,在MOOKP禁忌或难以实施时尤其有用。

研究设计与样本

  • 前瞻性病例系列,纳入2012至2016年56例患者(58眼,12名儿童和44名成人)行单侧LVP角膜假体植入,采用两阶段手术:先行眼表唇黏膜移植,3个月后在移植黏膜瓣下植入假体。

主要发现

  • Kaplan-Meier生存分析显示解剖保留率1年为90.8%±3.9%,2年为80%±5.7%,3至5年为76.6%±6.5%。
  • 儿童与成人5年生存率分别为91%和72%,差异无统计学意义(p=0.258)。
  • 约61.5%的眼维持20/400或更好视力,术后1年中位BCVA从光感提升至20/70(p<0.0001)。
  • 假体后膜形成、青光眼、玻璃体炎、眼内炎和全眼球炎的发生率分别为43%、26%、22%、12%和3%。

临床怎么用

  • 对于眼表完全干燥、传统角膜手术禁忌的双侧终末期角膜盲,LVP角膜假体可作为一种替代MOOKP的选择。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To describe the anatomical and functional outcomes of the novel LVP keratoprosthesis (Kpro), developed as an alternative to the modified osteo-odonto keratoprosthesis (MOOKP), in eyes with end-stage corneal blindness where conventional corneal surgeries are contraindicated. METHODS: This prospective case series included 58 eyes of 56 patients (12 children and 44 adults) with severe bilateral keratopathy and completely dry, dermalised ocular surfaces who underwent unilateral LVP Kpro implantation from 2012 to 2016. In this two-stage procedure, an ocular surface labial mucous membrane grafting was performed, followed for 3 months by the implantation of the device under the engrafted mucosal flap. The primary outcome measures were anatomical retention rate and improvement in best corrected visual acuity (BCVA). The secondary outcome measure was rate of occurrence of complications. RESULTS: Mean postoperative follow-up was 2.5±1.1 years. Kaplan-Meier survival analysis showed an anatomical retention rate of 90.8%±3.9% at 1 year, 80%±5.7% at 2 years and 76.6%±6.5% at 3-5 years. The survival rates were comparable in children and adults (91% vs 72% at 5 years, p=0.258). About 61.5% of eyes maintained 20/400 or better vision and median BCVA improved from perception of light to 20/70 at 1 year postoperatively (p<0.0001). Complications like retroprosthetic membrane formation, glaucoma, vitritis, endophthalmitis and panophthalmitis occurred in 43%, 26%, 22%, 12% and 3% of the eyes, respectively. CONCLUSION: The LVP Kpro is an effective procedure for the treatment of end-stage corneal blindness in completely dry eyes. The LVP Kpro can be particularly useful in situations where the MOOKP is contraindicated or difficult to perform.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Basu S, Nagpal R, Serna-Ojeda JC, et al. LVP keratoprosthesis: anatomical and functional outcomes in bilateral end-stage corneal blindness. Br J Ophthalmol. 2018. PMID: 29891734. doi:10.1136/bjophthalmol-2017-311649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。